Abbott Labs (ABT) PT Lowered to $115 at Piper Sandler After a 'Disappointing Q1'
Tweet Send to a Friend
Piper Sandler analyst Adam Maeder lowered the price target on Abbott Labs (NYSE: ABT) to $115.00 (from $135.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
